Citigroup
CDMO

Citigroup’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Citigroup’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-142,357
Closed -$1.76M – 6091
2024
Q4 		$1.76M Buy
142,357
+91,949
+182% +$1.05M ﹤0.01% 2919
2024
Q3 		$574K Buy
50,408
+18,685
+59% +$188K ﹤0.01% 3640
2024
Q2 		$227K Sell
31,723
-581,939
-95% -$4.45M ﹤0.01% 3819
2024
Q1 		$4.11M Buy
613,662
+460,216
+300% +$3.17M ﹤0.01% 1860
2023
Q4 		$997K Buy
153,446
+46,787
+44% +$302K ﹤0.01% 2823
2023
Q3 		$1.01M Sell
106,659
-55,939
-34% -$673K ﹤0.01% 2507
2023
Q2 		$2.27M Sell
162,598
-7,742
-5% -$132K ﹤0.01% 2084
2023
Q1 		$3.2M Sell
170,340
-10,025
-6% -$165K ﹤0.01% 1731
2022
Q4 		$2.48M Sell
180,365
-6,469
-3% -$99.1K ﹤0.01% 1876
2022
Q3 		$3.57M Buy
186,834
+38,015
+26% +$693K ﹤0.01% 1747
2022
Q2 		$2.27M Buy
148,819
+63,118
+74% +$934K ﹤0.01% 2015
2022
Q1 		$1.75M Sell
85,701
-94,427
-52% -$1.92M ﹤0.01% 2479
2021
Q4 		$5.26M Buy
180,128
+97,440
+118% +$2.79M ﹤0.01% 1793
2021
Q3 		$1.78M Sell
82,688
-43,905
-35% -$1.06M ﹤0.01% 2621
2021
Q2 		$3.25M Buy
126,593
+122,309
+2,855% +$2.61M ﹤0.01% 2277
2021
Q1 		$78K Sell
4,284
-6,981
-62% -$116K ﹤0.01% 4484
2020
Q4 		$130K Buy
11,265
+8,222
+270% +$75.2K ﹤0.01% 5326
2020
Q3 		$23K Sell
3,043
-4,967
-62% -$37.6K ﹤0.01% 6106
2020
Q2 		$53K Sell
8,010
-9,095
-53% -$50.8K ﹤0.01% 5992
2020
Q1 		$87K Buy
17,105
+5,536
+48% +$33.5K ﹤0.01% 5464
2019
Q4 		$89K Buy
11,569
+4,112
+55% +$24K ﹤0.01% 5861
2019
Q3 		$40K Sell
7,457
-8,479
-53% -$52.6K ﹤0.01% 6276
2019
Q2 		$89K Buy
15,936
+1,777
+13% +$7.33K ﹤0.01% 5976
2019
Q1 		$60K Buy
14,159
+900
+7% +$3.67K ﹤0.01% 6192
2018
Q4 		$54K Sell
13,259
-1,082
-8% -$5.65K ﹤0.01% 6178
2018
Q3 		$98K Buy
14,341
+6,619
+86% +$39.2K ﹤0.01% 5936
2018
Q2 		$31K Buy
7,722
+7,279
+1,643% +$25.3K ﹤0.01% 6661
2018
Q1 		$1K Hold
443
– – ﹤0.01% 7478
2017
Q4 		$2K Hold
443
– – ﹤0.01% 7411
2017
Q3 		$1K Buy
443
+16
+4% +$60 ﹤0.01% 7169
2017
Q2 		$2K Hold
427
– – ﹤0.01% 7041
2017
Q1 		$2K Hold
427
– – ﹤0.01% 7020
2016
Q4 		$1K Sell
427
-36
-8% -$84 ﹤0.01% 7139
2016
Q3 		$1K Hold
463
– – ﹤0.01% 7001
2016
Q2 		$1K Sell
463
-27,113
-98% -$75.6K ﹤0.01% 7005
2016
Q1 		$81K Buy
27,576
+18,496
+204% +$99K ﹤0.01% 5821
2015
Q4 		$75K Buy
9,080
+8,612
+1,840% +$69.5K ﹤0.01% 5617
2015
Q3 		$3K Sell
468
-413
-47% -$3.45K ﹤0.01% 6942
2015
Q2 		$8K Sell
881
-2,292
-72% -$22K ﹤0.01% 6583
2015
Q1 		$30K Sell
3,173
-1,522
-32% -$14.7K ﹤0.01% 5843
2014
Q4 		$46K Buy
4,695
+3,449
+277% +$34.7K ﹤0.01% 5746
2014
Q3 		$12K Sell
1,246
-99
-7% -$1.11K ﹤0.01% 6182
2014
Q2 		$18K Sell
1,345
-2,921
-68% -$36.8K ﹤0.01% 5864
2014
Q1 		$57K Sell
4,266
-8,063
-65% -$106K ﹤0.01% 5408
2013
Q4 		$120K Buy
12,329
+11,883
+2,664% +$112K ﹤0.01% 5110
2013
Q3 		$4K Buy
446
+9
+2% +$89 ﹤0.01% 6480
2013
Q2 		$4K Buy
+437
New +$4.58K ﹤0.01% 6403

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $426M AUM 23.62% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citigroup's CDMO Position: Q1 2025 in Review

Citigroup sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 142,357 shares — an estimated $1.76M sold.

Citigroup first reported a position in CDMO in Q2 2013 and held it in 47 quarters. The position peaked at $5.26M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Citigroup reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Citigroup sold 142,357 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.76M.
  • Citigroup first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 47 quarters.
  • Citigroup's Avid Bioservices, Inc. Common Stock position peaked at $5.26M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.